| Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer AP Juan Jesús Cruz, Alberto Ocaña, E Del Barco Annals of oncology 18 (3), 421-430, 2007 | 58 | 2007 |
| Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location R Seijas-Tamayo, J Fernández-Mateos, JC Adansa Klain, R Mesía, ... Clinical and Translational Oncology 18, 1114-1122, 2016 | 32 | 2016 |
| Influence of DNA mismatch repair (MMR) system in survival and response to immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC): retrospective analysis A Olivares-Hernández, E del Barco Morillo, C Parra Pérez, ... Biomedicines 10 (2), 360, 2022 | 21 | 2022 |
| Are there differences by sex in lung cancer characteristics at diagnosis?—a nationwide study A Ruano-Ravina, M Provencio, VC de Juan, E Carcereny, A Estival, ... Translational Lung Cancer Research 10 (10), 3902, 2021 | 20 | 2021 |
| Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the … R Hitt, L Iglesias, A López-Pousa, A Berrocal-Jaime, JJ Grau, ... Clinical and Translational Oncology 23, 764-772, 2021 | 16 | 2021 |
| Spanish Head and Neck Cancer Cooperative Group (TTCC). Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally … J Fernández-Mateos, R Seijas-Tamayo, R Mesía, M Taberna, ... Oral Oncol 63, 38-43, 2016 | 5 | 2016 |
| Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients … R Hitt, R Mesía, A Lozano, LI Docampo, JJ Grau, M Taberna, ... Oral Oncology 134, 106087, 2022 | 4 | 2022 |
| Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy A Olivares-Hernández, E del Barco Morillo, JP Miramontes-González, ... Frontiers in Bioscience-Landmark 27 (3), 88, 2022 | 4 | 2022 |
| Cáncer de cabeza y cuello E del Barco Morillo, AO Hernández Oncología clínica, 259-271, 2024 | 2 | 2024 |
| TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck J Rubió-Casadevall, B Cirauqui Cirauqui, J Martinez Trufero, ... Frontiers in Oncology 13, 1226939, 2023 | 2 | 2023 |
| 678P Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) BC Cirauqui, JM Trufero, MP Serrahima, AG Castaño, ... Annals of Oncology 33, S852-S853, 2022 | 2 | 2022 |
| Severe hyponatremia masking central diabetes insipidus in a patient with a lung adenocarcinoma E Terán Brage, M Heras Benito, MB Navalón Jiménez, R Vidal Tocino, ... Case Reports in Oncology 15 (1), 91-98, 2022 | 2 | 2022 |
| Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer LM Chinchilla-Tábora, JC Montero, LA Corchete, I González-Morais, ... International Journal of Molecular Sciences 25 (4), 2048, 2024 | 1 | 2024 |
| Cáncer de pulmón E del Barco Morillo, L Bellido, AO Hernández Oncología clínica, 227-257, 2024 | 1 | 2024 |
| Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study C Candal-Pedreira, A Ruano-Ravina, VC de Juan, M Cobo, JM Trigo, ... ERJ Open Research 9 (6), 2023 | 1 | 2023 |
| Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study M Provencio, E Carcereny, RL Castro, V Calvo, DR Abreu, M Cobo, ... Translational Lung Cancer Research 12 (10), 2113, 2023 | 1 | 2023 |
| Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data I Toribio-García, A Olivares-Hernández, JP Miramontes-González, ... Cancers 15 (17), 4293, 2023 | 1 | 2023 |
| Protocolo diagnóstico del dolor en el paciente oncológico E del Barco Morillo Medicine-Programa de Formación Médica Continuada Acreditado 9 (26), 1722-1725, 2005 | 1 | 2005 |
| Sarcomas TM Gómez, FA Arija, AA Sánchez-Morate, E del Barco Morillo Medicine-Programa de Formación Médica Continuada Acreditado 9 (26), 1704-1711, 2005 | 1 | 2005 |
| Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP AV Ospina, S Bolufer Nadal, JL Campo-Cañaveral de la Cruz, ... Clinical and Translational Oncology, 1-17, 2024 | | 2024 |
